ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Material basis and integrative pharmacology of danshen decoction in the treatment of cardiovascular diseases

Liu, Mengnan; Li, Ziyi; Ouyang, Yue; Chen, Mingtai; Guo, Xin; Mazhar, Maryam; Kang, Junli; Zhou, Hua*; Wu, Qibiao*; Yang, Sijin*广东省人民医院; 广州中医药大学
PHYTOMEDICINE2023-1DOI: 10.1016/j.phymed.2022.154503
2被引13阅读
引用收藏
分享

摘要

Background: Cardiovascular diseases (CVDs) are among the primary and predominant threats to human health with increasing incidence. Danshen Decoction (DSD) as an adjuvant therapy can benefit CVDs patients by improving clinical efficacy. @@@ Purpose: The purpose of this study was to identify the active components and potential pharmacological mechanisms of DSD by combining mass spectrometry with a network pharmacology strategy and to review the use of DSD in the treatment of CVDs. @@@ Method: First, the composition of DSD was analyzed by ultrahigh-performance liquid chromatography/tandem mass spectrometry (UHPLC-MS/MS). Second, the network pharmacology method was used to elucidate the underlying material basis and possible pharmacological mechanism of DSD for the treatment of CVDs. Finally, clinical and experimental studies on DSD in the past ten years were retrieved from the PubMed and CNKI database, and the content of these studies was used to summarize the latest progress in DSD treatment of CVDs. @@@ Outcome: A total of 35 compounds were found in DSD by manual identification from the analysis of MS, which may be the material basis for the therapeutic effect of DSD. After taking the intersection of 2086 targets related to CVDs, these 35 compounds are considered to play a role in the treatment of CVDs through 210 targets including signal transducer and activator of transcription 3 (STAT3), sarcoma (SRC) and phosphoinositide-3-kinase reg-ulatory subunit (PIK3R), and a total of 168 signaling pathways were involved in the regulation of CVDs by DSD, including PI3K-AKT signaling pathway, Alzheimer disease, and Rap1 signaling pathway. A total of 29 clinical studies using DSD in the treatment of CVDs were included in the literature review, and these studies showed the positive significance of DSD as adjuvant therapy, while 14 experimental studies included in the literature review also demonstrated the effectiveness of DSD in the treatment of CVDs. @@@ Conclusion: DSD plays a role in the treatment of CVDs through a variety of active ingredients. Large-scale clinical research and more in-depth experimental research will help to further reveal the mechanism of DSD in the treatment of CVDs.

学科与关键词

关键词
Danshen decoctionCardiovascular diseaseUHPLC-MS/MSNetwork pharmacologyClinical research
相关
加载中…
  • Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy
    Liu, Mengnan; Yuan, Gang; Luo, Gang; Guo, Xin; Chen, Mingtai; Yang, Huayi; He, Fan; Yang, Tingfu; Zhang, Xinyue; Wu, Qibiao*; Zhou, Hua*; Yang, Sijin*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 7578055.被引 6
  • Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis
    Bi, Yiming; Han, Xin; Lai, Yigui; Fu, Yingchang; Li, Kongzheng; Zhang, Wei; Wang, Qiang; Jiang, Xuefeng; Zhou, Yingchun*; Liang, Hongfeng*; Fan, Huijie*Journal of Ethnopharmacology, 2021, 278: 114278.被引 12
  • Metabolic profile and potential mechanisms of Wendan decoction on coronary heart disease by ultra-high-performance quadrupole time of flight-mass spectrometry combined with network pharmacology analysis
    Wang, Qi; Chen, Jiayun; Zhang, Yezi; Xu, Danping; Wu, Huanlin; Lin, Pei*; He, Liangliang; Qin, Zifei; Yao, Zhihong*Journal of Separation Science, 2023, 46(1).被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2023-01
卷期
第 108 卷
页码
154503
DOI
10.1016/j.phymed.2022.154503
语言
GERMAN
成果收录
SCIE

作者

  • L

    Liu, Mengnan (第一作者)

  • L

    Li, Ziyi

查看全部 10 位作者收起作者
  • O

    Ouyang, Yue

  • C

    Chen, Mingtai

  • G

    Guo, Xin

  • M

    Mazhar, Maryam

  • K

    Kang, Junli

  • Z

    Zhou, Hua (通讯)

    guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wu, Qibiao (通讯)

  • Y

    Yang, Sijin (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417